These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17269157)
1. Pharma faces major challenges after a year of failures and heated battles. Frantz S Nat Rev Drug Discov; 2007 Jan; 6(1):5-7. PubMed ID: 17269157 [No Abstract] [Full Text] [Related]
4. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
5. How should we support pharmaceutical innovation? Grootendorst P Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991 [TBL] [Abstract][Full Text] [Related]
6. What ails the FDA? Gorelick KJ N Engl J Med; 2005 Jun; 352(24):2553-4. PubMed ID: 15958814 [No Abstract] [Full Text] [Related]
7. [Small patients--big challenges]. Høeg E Tidsskr Nor Laegeforen; 2006 Jun; 126(13):1764. PubMed ID: 16794674 [No Abstract] [Full Text] [Related]
8. Pharma's year of trouble and strife. Frantz S Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339 [No Abstract] [Full Text] [Related]
9. Biotech drug market steadily expands. Lawrence S Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279 [No Abstract] [Full Text] [Related]
10. Toxicity testing in the 21st century: a view from the pharmaceutical industry. MacDonald JS; Robertson RT Toxicol Sci; 2009 Jul; 110(1):40-6. PubMed ID: 19435982 [No Abstract] [Full Text] [Related]
12. The quiet revolution: outsourcing in pharma. Crossley R Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780 [No Abstract] [Full Text] [Related]
13. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
14. Striking the right balance. Nat Rev Drug Discov; 2006 Nov; 5(11):879. PubMed ID: 17117516 [No Abstract] [Full Text] [Related]
15. In search of sustainability: process R&D in light of current pharmaceutical industry challenges. Federsel HJ Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405 [TBL] [Abstract][Full Text] [Related]
16. Pipelines turn to biotech. Lawrence S Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015 [No Abstract] [Full Text] [Related]
17. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf. Nesi T US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444 [No Abstract] [Full Text] [Related]
18. [Safety assessment of new products developed by the pharmaceutical industry]. Claude JR Ann Pharm Fr; 2001 Sep; 59(5):324-30. PubMed ID: 11787426 [TBL] [Abstract][Full Text] [Related]